Developing Target Therapy Against Oncogenic Tyrosine Kinase in Myeloid Maliganacies
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
331-337
Author(s):
Tomoki Naoe
Recent Advances in the Treatment of Multiple Myeloma
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
381-393
Author(s):
Hiroshi Yasui, Teru Hideshima, Paul G. Richardson and Kenneth C. Anderson
IgE, Allergic Diseases, and Omalizumab
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3929-3944
Author(s):
L. M. DuBuske
Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
553-563
Author(s):
Hironori Harada, Yuka Harada and Akiro Kimura
Anti-tumor Therapeutic Molecules that Target the Programmed Cell Death Machinery
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
6
Page:
1033-1042
Author(s):
Iva Ivanovska, Clare N. Muhoro and Pablo M. Irusta
Haematopoietic Stem Cell Gene Therapy to Treat Autoimmune Disease
Journal:
Current Stem Cell Research & Therapy
Volume:
1
Page:
279-287
Author(s):
Frank Alderuccio, Christopher Siatskas, James Chan, Judith Field, Kim Murphy, Zeyad Nasa and Ban-Hock Toh
Anthracyclines-Contra Cruciform Extrusion in DNA Regulating Sequences
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
295-302
Author(s):
Viktor Viglasky
Nelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
185-192
Author(s):
Sophie Curbo and Anna Karlsson
Reversal of Resistance to Oxazaphosphorines
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
385-407
Author(s):
Jing Zhang, Quan Tian, Yi-Zhun Zhu, An-Long Xu and Shu-Feng Zhou
Biological Basis of Novel Therapies for Myelodysplastic Syndrome
Journal:
Current Cancer Therapy Reviews
Volume:
2
Page:
199-209
Author(s):
Eyal C. Attar and Karen K. Ballen